1.Klevens, RM, Edwards, JR, Richards, CL, et al.Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122:160–166.
2.Scott, RD. The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention. Atlanta: Centers for Disease Control and Prevention, 2009.
3.Martin, J. The Impact of Healthcare-Associated Infections in Pennsylvania. Harrisburg, PA: Pennsylvania Health Care Cost Containment Council, 2011. http://www.phc4.org. Accessed February 28, 2013.
4.Boyce, JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 2007;65:50–54.
5.Blythe, D, Keenlyside, D, Dawson, SJ, Galloway, A. Environmental contamination due to methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1998;38:67–69.
6.Duckro, AN, Blom, DW, Lyle, EA, Weinstein, RA, Hayden, MK. Transfer of vancomycin-resistant enterococci via health care worker hands. Arch Intern Med 2005;165:302–307.
7.Hayden, MK, Blom, DW, Lyle, EA, Moore, CG, Weinstein, RA. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant Enterococcus or the colonized patients' environment. Infect Control Hosp Epidemiol 2008;29:149–154.
8.Kramer, A, Schwebke, I, Kampf, G. How long do nosocomial pathogens persist on inanimate surfaces? a systematic review. BMC Infect Dis 2006;6:130.
9.Huang, SS, Datta, R, Platt, R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006;166:1945–1951.
10.Shaughnessy, MK, Micielli, RL, DePestel, DD, et al.Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011;32:201–206.
11.Huskins, WC, Huckabee, CM, O'Grady, NP, et al.Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011;364:1407–1418.
13.Otter, JA, Yezli, S, French, GL. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 2011;32:687–699.
14.Otter, JA, Puchowicz, M, Ryan, D, et al.Feasibility of routinely using hydrogen peroxide vapor to decontaminate rooms in a busy United States hospital. Infect Control Hosp Epidemiol 2009;30:574–577.
15.Rutala, WA, Gergen, MF, Weber, DJ. Room decontamination with UV radiation. Infect Control Hosp Epidemiol 2010;31:1025–1029.
17.Michels, HT. Anti-microbial characteristics of copper. Stand News 2006;34:28–31.
18.Noyce, JO, Michels, H, Keevil, CW. Potential use of copper surfaces to reduce survival of epidemic methicillin-resistant Staphylococcus aureus in the healthcare environment. J Hosp Infect 2006;63:289–297.
19.Warnes, SL, Green, SM, Michels, HT, Keevil, CW. Biocidal efficacy of copper alloys against pathogenic enterococci involves degradation of genomic and plasmid DNAs. Appi Environ Microbiol 2010;76:5390–5401.
20.Weaver, L, Michels, HT, Keevil, CW. Survival of Clostridium difficile on copper and steel: futuristic options for hospital hygiene. J Hosp Infect 2008;68:145–151.
21.Weaver, L, Noyce, JO, Michels, HT, Keevil, CW. Potential action of copper surfaces on methicillin-resistant Staphylococcus aureus. J Appl Microbiol 2010;109:2200–2205.
22.Grass, G, Rensing, C, Solioz, M. Metallic copper as an antimicrobial surface. Appl Environ Microbiol 2011;77:1541–1547.
23.Mehtar, S, Wiid, I, Todorov, SD. The antimicrobial activity of copper and copper alloys against nosocomial pathogens and Mycobacterium tuberculosis isolated from healthcare facilities in the Western Cape: an in-vitro study. J Hosp Infect 2008;68:45–51.
24.Marais, F, Mehtar, S, Chalkley, L. Antimicrobial efficacy of copper touch surfaces in reducing environmental bioburden in a South African community healthcare facility. J Hosp Infect 2010;74:80–82.
25.Schmidt, MG, Attaway, HH, Sharpe, PA, et al.Sustained reduction of microbial burden on common hospital surfaces through the introduction of copper. J Clin Microbiol 2012;50(7):2217–2223.
26.Mikolay, A, Huggett, S, Tikana, L, Grass, G, Braun, J, Nies, DH. Survival of bacteria on metallic copper surfaces in a hospital trial. Appl Microbiol Biotechnol 2010;87:1875–1879.
27.Casey, AL, Adams, D, Karpanen, TJ, et al.Role of copper in reducing hospital environment contamination. J Hosp Infect 2010;74:72–77.
28.Karpanen, TJ, Casey, AL, Lambert, PA, et al.The antimicrobial efficacy of copper alloy furnishings in the clinical environment: a crossover study. Infect Control Hosp Epidemiol 2012;33:3–9.
29.Freitas, EF, Harris, RM, Blake, RK, Salgado, CD. Prevalence of USA300 community-acquired methicillin-resistant Staphylococcus aureus among patients with nasal colonization identified by active surveillance. Infect Control Hosp Epidemiol 2010;31:469–475.
30.Jain, R, Kralovic, SM, Evans, ME, et al.Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011;364:1419–1430.
31.Olivier, CA, Blake, RK, Steed, LL, Saigado, CD. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol 2008;29:404–409.
32.Sharpe, PA, Schmidt, MG. Control and mitigation of healthcare-acquired infections: designing clinical trials to evaluate new materials and technologies. Herd 2011;5(1):94–115.
33.Schmidt, MG, Anderson, T, Attaway, H, et al.Patient environment microbial burden reduction: a pilot study comparison of two terminal cleaning methods. Am J Infect Control 2012;40:559–561.
34.Horan, TC, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–332.
35.American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388–416.
36.Weber, DJ, Rutala, WA. Self-disinfecting surfaces. Infect Control Hosp Epidemiol 2012;33:10–13.